ORACLE CORP: Melius Research Increases Target Price to $170
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 11 2026
0mins
Source: moomoo
- Oracle Corporation Update: Oracle Corporation has raised its price target for Melious Research to $170.
- Market Impact: This adjustment reflects positive expectations for Melious Research's performance in the market.
Trade with 70% Backtested Accuracy
Analyst Views on ORAC
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

Oracle's Relationship with TRC: Oracle Corporation is not affiliated with TRC and does not endorse TRC's mini-tender offer.
Mini-Tender Offer Clarification: The statement emphasizes that Oracle does not support or recommend TRC's offer to purchase shares from Oracle's shareholders.
See More

Oracle Corporation Update: Oracle has received a buy rating from BofA Global Research, indicating positive sentiment towards the company's stock.
Price Target: The objective price set for Oracle's stock is $200, suggesting potential growth for investors.
See More
- Oracle Corporation Update: Oracle Corporation has raised its price target for Melious Research to $170.
- Market Impact: This adjustment reflects positive expectations for Melious Research's performance in the market.
See More
- Oracle Corporation Target Price Adjustment: Piper Sandler has reduced the target price for Oracle Corporation from $240 to $210.
- Market Implications: This adjustment reflects a shift in market expectations regarding Oracle's performance and potential growth.
See More
- Oracle Corp Target Price Cut: Exane BNP Paribas has reduced its target price for Oracle Corp from $290 to $201.
- Market Impact: This significant cut reflects changing market conditions and expectations for Oracle's future performance.
See More






